(Q38268525)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

Therapy-related peripheral neuropathy in multiple myeloma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

peripheral neuropathy

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Marek Hus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Marta Morawska

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Magdalena Kostyra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Jolanta Wojciechowicz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

14 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

published in

Hematological Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

113-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399783%20AND%20SRC:MED&resulttype=core&format=json

Dealing with neuropathy in plasma-cell dyscrasias

22 February 2020

cites work

1 reference

21 January 2018

1 reference

Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy

21 January 2018

1 reference

Neurological aspects of multiple myeloma and related disorders

21 January 2018

1 reference

Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board

21 January 2018

1 reference

Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy

21 January 2018

1 reference

Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma

21 January 2018

1 reference

Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature

21 January 2018

1 reference

Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy

21 January 2018

1 reference

Prevalence of peripheral neuropathy in multiple myeloma at initial diagnosis

21 January 2018

1 reference

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

21 January 2018

1 reference

Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline

21 January 2018

1 reference

Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.

21 January 2018

1 reference

Thalidomide-induced neuropathy: a ganglionopathy?

21 January 2018

1 reference

Thalidomide-induced neuropathy

21 January 2018

1 reference

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

21 January 2018

1 reference

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature

21 January 2018

1 reference

Peripheral nervous system involvement in patients with cancer

21 January 2018

1 reference

Chemotherapy-induced neuropathy

21 January 2018

1 reference

Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons.

21 January 2018

1 reference

Thalidomide has activity in treating complex regional pain syndrome

21 January 2018

1 reference

Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition.

21 January 2018

1 reference

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma

21 January 2018

1 reference

A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma

21 January 2018

1 reference

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

21 January 2018

1 reference

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

21 January 2018

1 reference

Bendamustine: rebirth of an old drug

21 January 2018

1 reference

Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma

21 January 2018

1 reference

Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.

21 January 2018

1 reference

Bendamustine: a review of its use in the management of chronic lymphocytic leukaemia, rituximab-refractory indolent non-Hodgkin's lymphoma and multiple myeloma

21 January 2018

1 reference

Management of treatment-emergent peripheral neuropathy in multiple myeloma.

21 January 2018

1 reference

Neurological monitoring reduces the incidence of bortezomib-induced peripheral neuropathy in multiple myeloma patients

21 January 2018

1 reference

Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid

21 January 2018

1 reference

Guidelines for the diagnosis and management of multiple myeloma 2011.

21 January 2018

1 reference

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

Neuropathy in multiple myeloma treated with thalidomide: a prospective study

21 January 2018

1 reference

Neuropathies associated with paraproteinemia

21 January 2018

1 reference

7 January 2021

The neuropathy of multiple myeloma. An electrophysiological and histological study

1 reference

7 January 2021

Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib

1 reference

7 January 2021

Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring

1 reference

7 January 2021

Thalidomide-induced bradycardia and its management.

1 reference

7 January 2021